TOP STORIES

• REGULATORY Kymriah in Line for Japan Approval Next Month as It Gets Key Panel Nod
  February 21, 2019

• REGULATORY Japan to Roll Out Cost-Effectiveness Assessment Scheme in April
  February 21, 2019

• REGULATORY Stemirac Fetches 15 Million Yen Price Tag, Peak Sales Put at 3.7 Billion Yen
  February 20, 2019

• COMMENTARY Restructuring, Divestment Progress in Wake of Drug Pricing Overhaul
  February 20, 2019

• ORGANIZATION EFPIA Japan Chief Says CEA Selection Criteria Mar Predictability, 5 Billion Yen Sales Threshold “Too Low”
  February 19, 2019

• BUSINESS As Japan Goes Digital on Package Inserts, Distributors Fret Proposed Paper-Based Rule on “1st Delivery”
  February 18, 2019

• BUSINESS Toa, Nipro, Nihon Generic Codeveloped Symbicort Copies, Launch Timing Unclear
  February 18, 2019

• REGULATORY Japan Approves Symbicort Generics, Asthma Drug Stalwart Could Face Competition in June
  February 15, 2019

• BUSINESS Ohara’s High-Need Pediatric Cancer Drug in Limbo 2 Years after Approval due to GMP Issue
  February 15, 2019

• BUSINESS Recordati Ratcheting Up Japan Biz, Set to Enrich Rare Disease Portfolio
  February 14, 2019

• BUSINESS Generic Player Ohara Looks to Morph into Innovative Drug Maker, with Focus on Oncology
  February 13, 2019

• TRENDS Rituxan Biosimilar Grabs 30% Volume Share in Just 1 Year; Sales Expected to Double in 2019
  February 12, 2019

• ORGANIZATION 2019 Is Year to “Get Things Right”: PhRMA Japan Chairman
  February 8, 2019

• REGULATORY Importance of Non-ICER Factors in Cost-Effectiveness Assessment Starting to Resonate with Chuikyo Reps
  February 7, 2019

• REGULATORY Kymriah Up for MHLW Panel Review on Feb. 20 as Japan’s 1st CAR-T Therapy
  February 6, 2019

• ORGANIZATION PhRMA Takes Issue with Japan Govt’s Overreliance on ICER, Proposes Point-Based Appraisal Framework
  February 5, 2019

• BUSINESS Sawai and 7 Other Generic Makers Seeking Lyrica Patent Invalidity
  February 4, 2019

• BUSINESS Oncolys Plans to Begin Japan PII Study of Oncolytic Virus in 2nd Half of 2019
  February 1, 2019

• REGULATORY Faulty Wage Data Might Have Affected Drug Pricing as Labor Stats Used for Cost-Based Method
  January 31, 2019

• TRENDS Drug Formulary Initiatives Moving Beyond Hospitals, Generic Makers Prepping for Regional Lists
  January 30, 2019

ページ

• « 先頭
• ‹ Prev
• …
• 133
• 134
• 135
• 136
• 137
• 138
• 139
• 140
• 141
• …
• Next ›
• 最終 »